Dexcom (NSDQ:DXCM) posted first-quarter results today that beat the consensus forecast on Wall Street but dropped its financial guidance for the year.
The San Diego-based company reported profits of $19.9 million, or 21¢ per share, on sales of $405.1 million for the three months ended March 31 on sales growth of 44.4% compared with Q1 2019.
Adjusted to exclude one-time items, earnings per share were 44¢, 29¢ ahead of The Street, where analysts were looking for sales of $358.7 million.